Reply to: Comments on “Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)”
Reply to: Comments on “Toxicity‐related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune‐based combinations (ARON‐1 study)” / Molina‐Cerrillo, J., Roviello, G., Fiala, O., Taha, T., Buti, S., Rizzo, M., Massari, F., Monteiro, F.S.M., Santoni, M.. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - STAMPA. - 158:(2026), pp. 1992-1994. [10.1002/ijc.70289]
Reply to: Comments on “Toxicity‐related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune‐based combinations (ARON‐1 study)”
Roviello, Giandomenico;
2026
Abstract
Reply to: Comments on “Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)”
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Molina‐Cerrillo et al. Int J of Cancer, 2026.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
295.99 kB
Formato
Adobe PDF
|
295.99 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
